This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
e.l.f. Beauty to Report Q2 Earnings: What Awaits ELF Stock?
by Zacks Equity Research
ELF's upcoming results hinge on Rhode's premium skincare boost, rising sales momentum, and ongoing tariff and cost pressures.
Earnings Preview: e.l.f. Beauty (ELF) Q2 Earnings Expected to Decline
by Zacks Equity Research
e.l.f. Beauty (ELF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
e.l.f. Beauty (ELF) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $126.18, marking a +2.74% move from the previous day.
e.l.f. Beauty (ELF) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
e.l.f. Beauty (ELF) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
e.l.f. Beauty (ELF) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $127.42, marking a -6.94% move from the previous day.
Estee Lauder Targets 25% of Sales From Innovation in Fiscal 2026
by Zacks Equity Research
EL aims for 25% of sales from innovation in fiscal 2026, driving growth across all major beauty categories.
Investors Heavily Search e.l.f. Beauty (ELF): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to e.l.f. Beauty (ELF). This makes it worthwhile to examine what the stock has in store.
e.l.f. Beauty (ELF) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
e.l.f. Beauty (ELF) concluded the recent trading session at $133, signifying a +2.55% move from its prior day's close.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Wall Street Bulls Look Optimistic About e.l.f. Beauty (ELF): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?